P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

P15-04. Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells

Bibliographic Details
Main Authors:	Gilbert P, Wang M, Wood B, Gao H, Greene KM, Ozaki DA, Yu X, Todd CA, Montefiori DC, Sarzotti-Kelsoe M
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

International technology transfer of a GCLP-compliant HIV-1 neutralizing antibody assay for human clinical trials.
by: Daniel A Ozaki, et al.
Published: (2012-01-01)

P11-07. Characterization of a new TZM-bl cell line that expresses human FcαR(CD89)
by: Montefiori DC, et al.
Published: (2009-10-01)

The TZM-bl Reporter Cell Line Expresses Kynureninase That Can Neutralize 2F5-like Antibodies in the HIV-1 Neutralization Assay
by: Vladimir Morozov, et al.
Published: (2022-01-01)

A modified TZM-bl assay (MoCo-TZA) documents replication-competent HIV in circulating monocytes despite 2 years of antiretroviral therapy initiated early during acute infection
by: B. Mitchell, et al.
Published: (2019-12-01)

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
by: Montefiori D, et al.
Published: (2009-10-01)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
by: Yunda Huang, et al.
Published: (2021-12-01)

First analysis of in-situ melting on TZM tiles at high field side of the first wall in EAST
by: Chuannan Xuan, et al.
Published: (2023-03-01)

Analysis of damage mechanisms in boronized TZM tiles from Alcator C-Mod fusion reactor operations
by: Hubley, Joseph Michael
Published: (2011)

One-step preparation, microstructure and properties of WRe/TZM gradient material for X-ray tube of CT scanner
by: Cuiliu Han, et al.
Published: (2021-11-01)

P04-26. Immunological tolerance prevents the expression of a broadly reactive neutralizing HIV-1 antibody
by: Kelsoe G, et al.
Published: (2009-10-01)

LabKey Server NAb: A tool for analyzing, visualizing and sharing results from neutralizing antibody assays
by: Gao Hongmei, et al.
Published: (2011-05-01)

High temperature fatigue characteristics of P/M and hot-forged W-Re and TZM for X-ray target of CT scanner
by: Harimon, Mohd Azhar, et al.
Published: (2018)

High temperature fatigue characteristics of P/M and hot-forgedW-Re and TZM for X-ray target of CT scanner
by: Harimon, Mohd Azhar, et al.
Published: (2018)

Numerical analysis of the powder mixed electrical discharge machining (PMEDM) process for TZM-molybdenum superalloy using finite element method
by: Kapil Surani, et al.
Published: (2024-02-01)

P04-18. Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
by: Polonis V, et al.
Published: (2009-10-01)

An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.
by: Anke Schultz, et al.
Published: (2012-01-01)

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS
by: Martina S. Wesley, et al.
Published: (2021-08-01)

The evaluation of machining performances and surface roughness of TZM-molybdenum superalloy processed by silicon carbide powder mixed EDM process using RSM and ANOVA
by: Kapil Surani, et al.
Published: (2024-03-01)

Effective joining between oxide dispersion strengthened tungsten-based material (ODS-W) and TZM alloy via spark plasma sintering technology
by: Dong-Guang Liu, et al.
Published: (2021-03-01)

Therapy for Burkitt’s lymphoma according to the BL-M-04 protocol: 12-year experience
by: E A Baryakh, et al.
Published: (2015-07-01)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
by: Stevens G, et al.
Published: (2009-10-01)

Effects of Lactobacillus fermentum CQPC04 on Lipid Reduction in C57BL/6J Mice
by: Ruokun Yi, et al.
Published: (2020-09-01)

P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
by: Reinherz EL, et al.
Published: (2009-10-01)

International network for comparison of HIV neutralization assays: the NeutNet report.
by: Fenyo, E, et al.
Published: (2009)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
by: Garnett Kelsoe, et al.
Published: (2013-12-01)

International network for comparison of HIV neutralization assays: the NeutNet report.
by: Eva Maria Fenyö, et al.
Published: (2009-01-01)

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections
by: Grosskurth H, et al.
Published: (2009-10-01)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
by: Labranche, CC, et al.
Published: (2018)

International network for comparison of HIV neutralization assays: the NeutNet report II.
by: Heyndrickx, L, et al.
Published: (2012)

International network for comparison of HIV neutralization assays: the NeutNet report II.
by: Leo Heyndrickx, et al.
Published: (2012-01-01)

Comparison of a Micro-Neutralization Test with the Rapid Fluorescent Focus Inhibition Test for Measuring Rabies Virus Neutralizing Antibodies
by: Todd G. Smith, et al.
Published: (2017-07-01)

HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
by: Laurent Verkoczy, et al.
Published: (2014-05-01)

Report concerning results of proficiency testing laboratory on assay of tobramycine and nystatin by microbiological method
by: Simona Sturzu, et al.
Published: (2013-05-01)

P04-28. Breadth and magnitude of neutralizing antibody responses in subjects infected with HIV-1 subtype D or recombinants in Rakai district, Uganda
by: Robb ML, et al.
Published: (2009-10-01)

A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies
by: Wychowski Czeslaw, et al.
Published: (2007-03-01)

The Effect of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> Bl-04 on Influenza A Virus Infection in Mice
by: Bryan Zabel, et al.
Published: (2023-10-01)

Evaluation of a Pseudovirus Neutralization Assay for SARS-CoV-2 and Correlation with Live Virus-Based Micro Neutralization Assay
by: Ahmed Majdi K. Tolah, et al.
Published: (2021-05-01)

Self-Monitoring of Emotions and Mood Using a Tangible Approach
by: Federico Sarzotti
Published: (2018-01-01)

Doc. dr hab. Maria Chmielewska (15.04.1920 – 14.04.2016)
by: Zofia Sulgostowska
Published: (2016-01-01)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
by: Wang S, et al.
Published: (2009-10-01)